ClinicalTrials.gov record
Migraine Study in Adolescent Patients
ClinicalTrials.gov ID: NCT00843024
Public ClinicalTrials.gov record NCT00843024. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
TXA107979: A Randomized, Multicenter, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of a Combination Product Containing Sumatriptan and Naproxen Sodium for the Acute Treatment of Migraine in Adolescents
Study identification
- NCT ID
- NCT00843024
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- GlaxoSmithKline
- Industry
- Enrollment
- 589 participants
Conditions and interventions
Conditions
Interventions
- Sumatriptan and Naproxen Sodium Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2008
- Primary completion
- Apr 30, 2010
- Completion
- May 31, 2010
- Last update posted
- Jan 17, 2017
2008 – 2010
United States locations
- U.S. sites
- 79
- U.S. states
- 33
- U.S. cities
- 74
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GSK Investigational Site | Gilbert | Arizona | 85234 | — |
| GSK Investigational Site | Litchfield Park | Arizona | 85340 | — |
| GSK Investigational Site | Phoenix | Arizona | 85013 | — |
| GSK Investigational Site | Phoenix | Arizona | 85014 | — |
| GSK Investigational Site | Phoenix | Arizona | 85016 | — |
| GSK Investigational Site | Conway | Arkansas | 72034 | — |
| GSK Investigational Site | Little Rock | Arkansas | 72202 | — |
| GSK Investigational Site | Little Rock | Arkansas | 72205 | — |
| GSK Investigational Site | Chico | California | 95926 | — |
| GSK Investigational Site | Fresno | California | 93720 | — |
| GSK Investigational Site | Fullteron | California | 92835 | — |
| GSK Investigational Site | Huntington Beach | California | 92647 | — |
| GSK Investigational Site | Newport Beach | California | 92660 | — |
| GSK Investigational Site | Roseville | California | 95678 | — |
| GSK Investigational Site | Sacramento | California | 95815 | — |
| GSK Investigational Site | Sacramento | California | 95816 | — |
| GSK Investigational Site | San Francisco | California | 94109 | — |
| GSK Investigational Site | Santa Monica | California | 90404 | — |
| GSK Investigational Site | Colorado Springs | Colorado | 80907 | — |
| GSK Investigational Site | Fairfield | Connecticut | 06824 | — |
| GSK Investigational Site | Gainesville | Florida | 32607 | — |
| GSK Investigational Site | Hialeah | Florida | 33010 | — |
| GSK Investigational Site | Miami | Florida | 33155-3009 | — |
| GSK Investigational Site | Pensacola | Florida | 32504 | — |
| GSK Investigational Site | West Palm Beach | Florida | 33407 | — |
| GSK Investigational Site | Atlanta | Georgia | 30342 | — |
| GSK Investigational Site | Savannah | Georgia | 31405 | — |
| GSK Investigational Site | Stockbridge | Georgia | 30281 | — |
| GSK Investigational Site | Chicago | Illinois | 60642 | — |
| GSK Investigational Site | Oak Lawn | Illinois | 60453 | — |
| GSK Investigational Site | Park Ridge | Illinois | 60068 | — |
| GSK Investigational Site | Anderson | Indiana | 46011 | — |
| GSK Investigational Site | Terre Haute | Indiana | 47802 | — |
| GSK Investigational Site | Kansas City | Kansas | 66160 | — |
| GSK Investigational Site | Wichita | Kansas | 67207 | — |
| GSK Investigational Site | Bardstown | Kentucky | 40004 | — |
| GSK Investigational Site | Lexington | Kentucky | 40509 | — |
| GSK Investigational Site | Pikesville | Maryland | 21208 | — |
| GSK Investigational Site | Worcester | Massachusetts | 01605 | — |
| GSK Investigational Site | Ann Arbor | Michigan | 48104 | — |
| GSK Investigational Site | Plymouth | Minnesota | 55441 | — |
| GSK Investigational Site | Springfield | Missouri | 65807 | — |
| GSK Investigational Site | St Louis | Missouri | 63141 | — |
| GSK Investigational Site | Omaha | Nebraska | 68130 | — |
| GSK Investigational Site | Henderson | Nevada | 89014 | — |
| GSK Investigational Site | Vorhees | New Jersey | 08043 | — |
| GSK Investigational Site | Willingboro | New Jersey | 08046 | — |
| GSK Investigational Site | Albuquerque | New Mexico | 87108 | — |
| GSK Investigational Site | Amherst | New York | 14226 | — |
| GSK Investigational Site | Mineola | New York | 11501 | — |
| GSK Investigational Site | Mount Vernon | New York | 10550 | — |
| GSK Investigational Site | Schenectady | New York | 12308 | — |
| GSK Investigational Site | Raleigh | North Carolina | 27607 | — |
| GSK Investigational Site | Cincinnati | Ohio | 45229 | — |
| GSK Investigational Site | Cincinnati | Ohio | 45245 | — |
| GSK Investigational Site | Cleveland | Ohio | 44195 | — |
| GSK Investigational Site | West Chester | Ohio | 45069 | — |
| GSK Investigational Site | Westerville | Ohio | 43081 | — |
| GSK Investigational Site | Oklahoma City | Oklahoma | 73112 | — |
| GSK Investigational Site | Eugene | Oregon | 97401 | — |
| GSK Investigational Site | Portland | Oregon | 97210 | — |
| GSK Investigational Site | Salem | Oregon | 97301 | — |
| GSK Investigational Site | Philadelphia | Pennsylvania | 19139 | — |
| GSK Investigational Site | Pittsburgh | Pennsylvania | 15236 | — |
| GSK Investigational Site | Greer | South Carolina | 29651 | — |
| GSK Investigational Site | Simpsonville | South Carolina | 29681 | — |
| GSK Investigational Site | Bristol | Tennessee | 37620 | — |
| GSK Investigational Site | Clarksville | Tennessee | 37043 | — |
| GSK Investigational Site | Dallas | Texas | 75230 | — |
| GSK Investigational Site | Houston | Texas | 77030-2303 | — |
| GSK Investigational Site | San Antonio | Texas | 78258 | — |
| GSK Investigational Site | Salt Lake City | Utah | 84107 | — |
| GSK Investigational Site | Charlottesville | Virginia | 22902 | — |
| GSK Investigational Site | Norfolk | Virginia | 23510 | — |
| GSK Investigational Site | Seattle | Washington | 98195-6097 | — |
| GSK Investigational Site | Vancouver | Washington | 98686 | — |
| GSK Investigational Site | Wenatchee | Washington | 98801 | — |
| GSK Investigational Site | Madison | Wisconsin | 53715 | — |
| GSK Investigational Site | Middleton | Wisconsin | 53562-2215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00843024, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 17, 2017 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00843024 live on ClinicalTrials.gov.